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Objective: The objective of this study was to analyze our long-term results after open surgery for popliteal artery aneurysm.
Methods: Records of patients who received surgery between 1998 and 2010 were retrieved from a computerized database
and analyzed retrospectively. End points of the study were perioperative mortality and morbidity and patency and limb
salvage rate.
Results: Two hundred and six popliteal aneurysms (median diameter, 30 mm; interquartile range, 18 mm) were treated
(161 elective, 45 emergent) in 154 patients (mean age, 67 6 11 years) using vein grafts (82%) via the medial approach
(92%). Above-knee popliteal artery (45%) and below-knee popliteal artery (65%) were the predominant inﬂow and
outﬂow vessels. The overall surgical mortality was 2% (2% for elective and 3% for emergent procedures; P [ not sig-
niﬁcant). Primary, assisted primary, and secondary patency rates were 88.1% (73.5%), 92.1% (84.3%), and 96.5% (89.8%)
at 5 (at 10) years, respectively, with no signiﬁcant difference between elective and emergent surgeries. Limb salvage rate
was signiﬁcantly reduced in the emergent group vs the elective group with 91.1% vs 98.6% at 5 and 10 years (P[ .0049).
The rate of freedom from any reintervention was 84.3% at 5 and 69.8% at 10 years, respectively.
Conclusions: Open surgery for popliteal artery aneurysm is marked by low perioperative mortality and morbidity and
provides excellent long-term results. (J Vasc Surg 2014;60:951-7.)Although uncommon in the general population, with outcome after open surgical treatment and currently, limb
an estimated incidence of less than 0.1%, popliteal artery
aneurysms are considered to be the most common periph-
eral aneurysms (70%).1 Most popliteal aneurysms are
asymptomatic, however, in 20%, presentation is acute and
limb loss is imminent because of aneurysm thrombosis or
peripheral embolism.2
First described >4000 years ago, surgical treatment of
popliteal aneurysms has made a considerable evolution.
Initial attempts of proximal anddistal ligationwere described
in the early 18th century (“Antyllus technique”) but were
endowed with a considerable “failure rate.” They were
further reﬁned in the famous surgery performed by John
Hunter in 1785 with proximal ligation distant from the
neck (“Hunterian ligation”). After attempts of local recon-
structive procedures (restorative aneurysmorraphy byMatas
in 1903), milestones of surgical ingenuity that mark the
advent of the modern era were the technique of aneurysm
exclusion and short interposition grafting using reversed
saphenous vein introduced by Erich Lexer in 1912, and
the proximal and distal ligation combined with vein bypass
via the medial approach ﬁrst described by Edwards in
1969.3 Since then, multiple studies were published on thethe Division of Vascular Surgery, Department of Cardiothoracic and
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://dx.doi.org/10.1016/j.jvs.2014.04.035loss rates of 0% to 1% can be anticipated in asymptomatic pa-
tients, and in patients presenting with acute symptoms, a
limb loss rate of 3% to 30% has been observed.2
However, only a few studies exist that involve more
than 100 cases, and long-term data extending beyond
5 years are equally sparse. This is of great interest, because
the well established concept of open surgical treatment is
becoming increasingly challenged by the endovascular ther-
apy of popliteal aneurysms that was introduced in 1994.4
Therefore, the aim of the study was to review and share
our results of open surgery for popliteal artery aneurysm
with special attention to long-term outcome.
METHODS
From the computerized database of the Division of
Vascular Surgery, records of 154 consecutive patients who
received surgery for popliteal artery aneurysm in the period
between January 1998 and January 2010 (total number of
infrainguinal reconstructions: 2758) were retrieved and
complete patient charts were analyzed retrospectively. All
patients had signed informed consent for the procedure,
and approval of the study by the local ethics committee
was waived due to the retrospective design of the study.
The patient demographic characteristics are given in
Table I. Patient risk factors were deﬁned as follows: hyper-
tension (controlled with $one drug), diabetes (oral antidi-
abetic medication and/or insulin therapy), nicotine abuse
(active smoking of $one pack per day), hyperlipidemia
(controlled with $one drug), coronary artery disease
(history of $one vessel disease), renal insufﬁciency (serum
creatinine $2 mg/dL), end-stage renal disease (permanent
hemodialysis).
Preoperative imaging consisted of either high-
resolution computed tomography angiography, magnetic
resonance angiography, or ﬁne-needle digital subtraction951
Table I. Patient characteristics (N ¼ 154)
Characteristic Value
Mean age 6 SD (range), years 67 6 11 (40-95)
Sex (male/female) 148/6 (96/4)
Hypertension 118 (77)
Nicotine abuse 74 (48)
Hyperlipidemia 71 (46)
Diabetes mellitus 23 (15)
Coronary artery disease [CABG] 52 [21] (34 [14])
Renal insufﬁciency (end-stage renal disease) 22 [11] (14 [7])
ASA class III/IV 70/65 (46/42)
ASA, American Society of Anesthesiologists; CABG, coronary artery bypass
grafting; SD, standard deviation.
Data are presented as number (%) except where otherwise noted.
Table II. Indication and surgical details (N ¼ 206
surgeries)
Indication No. (%)
Asymptomatic 117 (57)
Disabling claudication 44 (21)
Thrombosed aneurysm 41 (20)
Ruptured aneurysm 4 (2)
Site of proximal
anastomosis
Femoral [CFA/DFA] 41 [33/8] (20 [16/4])
Femoral, SFA 72 (35)
Popliteal, SI 93 (45)
Site of distal anastomosis
Popliteal, SIII 134 (65)
Tibial: tibioperoneal
trunk/anterior/
posterior/peroneal
70 [21/25/10/14] (34 [10/12/5/7])
Pedal, dorsal 2 (1)
Sequential
anastomosis,
popliteal/tibial
19 [4/15] (9 [2/7])
Bypass graft
GSV 165 (80)
Arm vein 3 (2)
Prosthetic (HUV,
Omniﬂow II)
28 (14)
Composite (prosthetic
and GSV) graft
10 (5)
Approach
Medial/dorsal 190/16 (92/8)
CFA, Common femoral artery; DFA, deep femoral artery; GSV, greater
saphenous vein; HUV, human umbilical vein (Bio Vascular Inc, St. Paul,
Minn); SFA, superﬁcial femoral artery; SI, popliteal artery segment I;
SIII, popliteal artery segment III.
The Omniﬂow II is manufactured by Bio Nova International Pty Ltd,
North Melbourne, Australia.
JOURNAL OF VASCULAR SURGERY
952 Dorweiler et al October 2014angiography in selected cases (using carbon dioxide for pa-
tients with renal impairment). Quality and putative length
of venous conduit was assessed using preoperative vein-
mapping using duplex ultrasound.
The surgeries were performed using general anaesthesia
and the surgical details are listed inTable II. For nonreversed
grafts, side branches were ligated and valves were destroyed
using the “Mills” valvulotome (Teleﬂex Medical, Research
Triangle Park, NC). For in situ grafts, destruction of vein
valves was accomplished using a distally inserted catheter-
mounted valvulotome (LeMaitre, Vascutech, Burlington,
Mass). After completion of the proximal anastomosis, vein
valves were cut and major side branches were identiﬁed
and ligated using a ﬂow probe (CM 4008; Cardiomed,
Oslo, Norway). After demonstration of a sufﬁcient distal
pulse, the distal anastomosis was completed. Intraoperative
quality control was performed using transit time ﬂow mea-
surement (Cardiomed) and digital subtraction angiography
in selected cases. Grafts were routinely anastomosed in an
end-to-end fashion and in cases of perfused aneurysm, selec-
tive ligation of the adjacent popliteal artery was performed.
In selected cases (ie, thrombosed aneurysm) an end-to-side
anastomosis was used. In case of absence or insufﬁcient
length of vein graft, we used prosthetic biografts using either
the human umbilical vein (HUV; Bio Vascular Inc, St. Paul,
Minn) or the Omniﬂow II biograft (Bio Nova International
Pty Ltd, North Melbourne, Australia). For selective intrao-
perative intra-arterial lysis of tibial outﬂow vessels in acutely
thrombosed popliteal aneurysms, 100,000 IUurokinasewas
applied per patient.
All patients received intravenous anticoagulation
(unfractionated heparin) following a staged application
scheme in the ﬁrst three postoperative days of 500 IU
unfractionated heparin on the day of surgery, 800 IU
unfractionated heparin at postoperative day 1, and 1000
IU of unfractionated heparin at day 2. At day 4, activated
partial thromboplastin time was adjusted to 60 to 70 sec-
onds. Intravenous anticoagulation was replaced by oral anti-
coagulation (target international normalized ratio, 2.5-3.0)
before discharge in the absence of contraindications.5
The postoperative imaging protocol consisted of
duplex ultrasound for all reconstructions and computed to-
mography scan or magnetic resonance angiography inselected cases. Patients were entered into a routine
follow-up program with clinical and duplex ultrasound ex-
aminations at 1, 3, and 12 months with annual repetitions
thereafter (Division of Angiology), complemented with
computed tomography angiography/magnetic resonance
angiography in selected cases (graft stenoses/aneurysmal
dilatation). In addition, for the purpose of this study, sur-
vival and limb salvage information was retrieved by contact-
ing living patients (phone interview) or their general
physician (deceased patients) for all cases.
For patency analysis, the latest date of objective proof
of patency (duplex ultrasound) was used and patency rates
were calculated using the Kaplan-Meier method using the
following deﬁnitions: a graft was considered to have pri-
mary patency if it had uninterrupted patency with no pro-
cedure performed on it. If graft patency could successfully
be restored after occlusion, it was considered to have sec-
ondary patency. For assisted primary patency, grafts were
considered when patency was never lost but maintained
using prophylactic intervention such as patch, percuta-
neous intervention, and partial graft replacement (retain-
ing most of the graft and at least one anastomosis in
continuity). Placement of an entire new graft in cases of
thrombosed bypass (“redo operation”) was not considered
for secondary patency. For the analysis of freedom from
Table III. Early results (30 days)
Result
Overall,
No. (%)
Elective,
No. (%)
Emergent,
No. (%) P
Mortality 3 (2) 2 (2) 1 (3) .8566
Graft occlusion 9 (4) 5 (3) 4 (9) .0942
Thrombectomy 8 (4) 5 (3) 3 (7) .2766
Hematoma 16 (8) 11 (7) 5 (11) .3455
Fasciotomy 11 (5) 4 (3) 7 (16) .0005
Major
amputation
4 (2) 0 (0) 4 (9) .0002
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marily patent grafts with no secondary graft procedures
(thrombectomy/service procedure) or amputations was
calculated. Statistical analysis (Kaplan-Meier) was per-
formed using GraphPad Prism 3 (Graphpad Software Inc,
San Diego, Calif) using a t-test for categorical and Mann-
Whitney test for continuous variables; a P value of <.05
was considered statistically signiﬁcant. For Kaplan-Meier
analysis, curves were terminated when the number of
subjects at risk was <10% of baseline or standard error of
the mean exceeded 10%.
RESULTS
During a 12-year period (1998-2010), 154 patients
(96% men) received surgery for a popliteal artery aneurysm
(Table I). Forty-ﬁve surgeries were performed as an emer-
gency procedure because of acutely thrombosed aneurysms
with critical limb ischemia or ruptured aneurysms.
Most (88%) of the patients had considerable comorbidity
(American Society of Anesthesiologists class III and IV).
We observed a rate of 31% bilateral disease (47 patients)
and a coincidence with abdominal aortic aneurysms in
32% (49 patients). Additionally, ﬁve patients had redo op-
erations (placement of an entire new graft) on the same
limb; one patient had two redo operations, and four pa-
tients had one redo operation.
This led to a total number of 206 surgeries (Table II).
The median diameter of the aneurysms was 30 (interquartile
range, 18) mmwith a range between 12mm and 85mm and
most of the surgeries (57%) were performed for asymptom-
atic aneurysms. A disabling claudication was present in 21%
of the patients because of occlusion of tibial vessels as a conse-
quence of previous distal embolization or concomitant
atherosclerotic occlusive disease. The mean surgery time
for all procedures was 205 6 70 minutes, with emergency
procedures being signiﬁcantly longer than elective surgeries
(228 6 74 minutes vs 192 6 35 minutes; P ¼ .0131).
The predominant inﬂow and outﬂow vessels were popliteal
artery segment I (45%) and III (65%), respectively. However,
the actual number of short interposition grafts (popliteal ar-
tery segments I-III) was only 70 (34%) and the most of the
grafts had either more proximal inﬂow (superﬁcial femoral ar-
tery, common femoral artery) or more distal outﬂow (tibial).
The autologous vein served as a conduit in most cases (82%).
In case of insufﬁcient vein length (18%), it was our policy to
use biological grafts. Here, the HUV (Bio Vascular Inc) graft
was used until 2006, and since 2006 it was replaced with the
Omniﬂow II (Bio Nova International Pty Ltd) biograft
because the HUV graft had been withdrawn from the mar-
ket. Vein grafts were oriented in the transposed, nonreversed
fashion inmost cases (63%), reversed grafts were used in 12%,
and in situ grafts were placed in 25% (predominantly for long
femorotibial grafts).
The early results are given in Table III. Three patients
(two in the elective and one in the emergency group) died
within 30 days, leading to an overall perioperative mortality
rate of 2%. In the elective group, one patient died at the
age of 89 years due to myocardial infarction atpostoperative day 8 and one patient with chronic pulmo-
nary hypertension and a history of pulmonary thromben-
darterectomy for recurrent pulmonary embolism died of
right ventricular failure at postoperative day 16. In the
emergency group, one patient died of myocardial infarction
at postoperative day 5.
Nine early graft occlusions were noted with eight grafts
that could be successfully treated using thrombectomy. In
one patient of the emergency group with extensive tissue
necrosis due to extended preoperative ischemia, no redo
operation for graft occlusion was attempted; instead, an
above-knee amputation was performed. Three graft occlu-
sions occurred in prosthetic grafts (8%), and six in vein
grafts (4%). In seven patients of the emergency group
and four patients of the elective group, fasciotomy was per-
formed. In the latter cases, development of compartment
syndrome was due to hyperperfusion after two proximally
occluded tibial arteries were revascularized using sequential
bypass. Fasciotomy wounds were either treated with sec-
ondary closure (n ¼ 3) or skin grafting (n ¼ 6). Four major
amputations were necessary in the early postoperative
period: in addition to the amputation already mentioned,
three above-knee amputations were performed despite pat-
ent bypass grafts due to extensive soft-tissue damage.
Intraoperative selective thrombectomy of tibial outﬂow
vessels and selective lysis of vessels in cases in which a
descending thrombosis into tibial arteries had occurred
was performed in 16 patients (36%) of the emergency group.
The late results in this study showed a median follow-
up of 137 (range, 1-185) months with an overall survival
rate of 63.5% at 5 years and 40.8% at 10 years and no sig-
niﬁcant difference between elective and emergent surgeries
(P ¼ .7636; Fig 1). Twelve graft occlusions were noted at
postoperative intervals between 2 and 127 months. For all
graft occlusions (early and late), no signiﬁcant difference
was noted in primary patency of vein vs prosthetic grafts
(P ¼ .0678). Three graft occlusions were treated using
thrombectomy, one patient (femoropopliteal [segment
III] bypass) received thrombectomy and distal graft exten-
sion (to the anterior tibial artery), and in three cases, the
occluded graft was replaced by a new graft. One patient
required below-knee amputation and in four cases, graft
occlusion was managed conservatively. The resulting pri-
mary and secondary patency rates were 88.1% and 96.5%
at 5 years and 73.5% and 89.8% at 10 years (Fig 2).
When primary and secondary patency rates were separately
Fig 1. Kaplan-Meier analysis of overall patient survival. In subgroup analysis, survival in the elective and emergent
group was not signiﬁcantly different (P ¼ .7636). SEM, Standard error of the mean.
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signiﬁcant difference was noted (P ¼ .1031 and .2997 for
primary and secondary patency rates, respectively). Second-
ary procedures encompassed patch plasty (n ¼ 5), proximal
(n ¼ 8) and distal (n ¼ 2) graft replacement (maximum
one-third of graft length), and percutaneous angioplasty
(n ¼ 1). Six of the eight proximal grafts replacements
were necessary because of aneurysmal degeneration of a
vein graft. The corresponding assisted primary patency
rate was 92.1% at 5 years and 84.3% at 10 years (Fig 2)
with no statistical signiﬁcance between elective and emer-
gent surgeries (P ¼ .2259). Two amputations at 9 months
postoperatively were necessary, one above the knee in a pa-
tient with prosthetic graft infection (HUV graft; Bio
Vascular Inc) and a below-knee amputation because of
graft occlusion (mentioned previously). The overall limb
salvage rate was 96.9% at 5 and 10 years, however, because
of the signiﬁcant difference in perioperative amputation
rate, limb salvage was signiﬁcantly reduced in the emer-
gency group with a rate of 91.1% at 5 and 10 years
compared with the elective group (98.6%; P ¼ .0049).
As a composite outcome parameter, we analyzed the
freedom from any reintervention for patients having no
secondary procedure or amputation (Fig 3) and were
able to show a rate of 84.3% at 5 years and 69.8% at 10 years
of follow-up with no signiﬁcant difference between elective
and emergent surgeries (P ¼ .0915).
Duplex ultrasound follow-up examination revealed
12 (6%) popliteal aneurysms with continuing perfusion
through collateral vessels (medial genicular artery).However, no aneurysm ruptures were noted and no sec-
ondary procedures had to be performed for perfused aneu-
rysms. In addition, aneurysmal vein graft degeneration was
noted in 19 grafts (9%), in six cases of relevant aneurysm
formation (>20 mm), proximal graft replacement was per-
formed (previously noted); in the remaining cases, aneu-
rysmal degeneration was mild-moderate and was
managed nonsurgically. For anticoagulation, most patients
(n¼ 172; 84%) received oral anticoagulation (phenprocou-
mon; target international normalized ratio, 2.0), and 34
patients (16%) were given platelet aggregation inhibitors.
DISCUSSION
The results after open surgery for popliteal artery aneu-
rysm have recently been reviewed and show a mean surgical
mortality of 2%, a secondary patency of 81% at 3 years, and
an amputation rate of 7% at 1 year and 4% at 3 years.6
However, the mean number of surgeries per study was
75 and a Kaplan-Meier analysis of patency and limb salvage
could not be performed because of the inhomogenicity of
reported data. To date, the two largest single-center series
are the studies by Huang et al7 (n ¼ 358) and Pulli et al8
(n ¼ 156) with primary, secondary patency, and limb
salvage rates of 76%, 87%, 97% and 66%, 83%, 87% at
5 years, respectively, and an operative mortality of 1%
and 2.1%, respectively.
Our results at 5 years with a primary and secondary
patency and limb salvage rate of 88.1%, 96.5%, and
96.9% compare well with the above reports. In addition,
we were able to provide robust follow-up data extending
Fig 2. Kaplan-Meier analysis of overall primary, assisted primary patency, and secondary patency. In subgroup analysis
no signiﬁcant difference was found for primary patency, assisted primary patency, and secondary patency between the
elective and the emergent group (P ¼ .1031 for primary patency, P ¼ .2259 for assisted primary patency, and
P ¼ .2997 for secondary patency). SEM, Standard error of the mean.
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patency and a limb salvage rate of 73.5%, 89.8%, and
96.9% was observed. This is important, because none of
the studies described herein provided limb salvage data
beyond 5 years. In general, patency rates in this study of
aneurysmal disease with a secondary patency of 96.5%
and 89.8% at 5 and 10 years, respectively, for elective cases
were excellent and superior to those commonly encoun-
tered in infrainguinal occlusive disease, a ﬁnding that has
been well described and is attributed to expansive remodel-
ing of the vein graft.9 Cases of extensive remodeling leading
to vein graft aneurysm formation have been observed in 9%
in our series and in up to 42% in a series of 24 infrainguinal
bypass grafts in patients with popliteal aneurysms and again
are attributed to the systemic nature of the disease.10
We observed an inferior outcome in terms of limb
salvage in patients who presented with acute ischemia:
here, the early amputation rate was 9% in our series, which
is slightly less than the amputation rate of 14.1% observed
in a large meta-analysis of 895 cases.11 However, with a
limb salvage rate of 91.1% at 5 and 10 years, the results of
emergent procedures for acute ischemia are signiﬁcantly
less than the limb salvage rate for elective cases (98.6% at 5and 10 years), a ﬁnding also reported by other groups.8,12,13
For graft patency, however, we did not observe a signiﬁcant
difference for elective vs emergent surgeries.
Endovascular treatment of popliteal artery aneurysms
was ﬁrst introduced in 1994 when an asymptomatic large
aneurysm in a 63-year-old patient with advanced heart dis-
ease and multiple episodes of congestive heart failure was
successfully excluded using insertion of a self-made device
constructed of a polytetraﬂuoroethylene graft (6 mm) su-
tured to a balloon-expandable stent (Palmaz).4
In a literature survey, reported mortality and morbidity
for endovascular therapy consistently are minimal, but
patency rates show considerable variation of between 75%
and 100% at 12 months.2 Furthermore, follow-up time in
general is short with only two reports proving robust
long-term (5-year) data with secondary patency rates of
76% and 86%.14,15
Currently, the only available prospective randomized
study that compared open and endovascular therapy
compared groups of 15 patients each, and no statistical dif-
ference was noted for primary and secondary patency at 12
and 36 months, however, limitations of the study were
reduced statistical power and short follow-up.15
Fig 3. Kaplan-Meier analysis of freedom from any reintervention (FFRI). The percentage of patients with primarily
patent grafts without any secondary intervention or amputation is given. In subgroup analysis, rates for FFRI were not
signiﬁcantly different for emergent vs elective surgeries (P ¼ .0915). SEM, Standard error of the mean.
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meta-analyses have been conducted, showing that open
repair had clear advantages in terms of graft thrombosis
and reintervention rate,16 and graft patency at 1 and 3 years
still was in favor of open repair.17
There is also consensus that further long-term follow-up
is required to enable comparison of the two treatment
modalities to determine the optimalmanagement strategy.18
Reduced invasiveness is one of the key arguments in
favor of endovascular therapy and most small studies report
mortality rates of 0%.2 However, there is a considerable span
of 0% to 11% with a mean mortality of 0.4%,6 and in the
largest series on endovascular therapy of popliteal aneu-
rysms, a perioperative mortality of 1.5% was encountered.19
For open repair, mortality rates of 1%,7 1.6%,12 and 2.1%8
were observed in large single-center series and a recent
meta-analysis stated a mean mortality of 2% (60/2838).6
In our study, overall perioperativemortality was 2%, thus be-
ing comparable with the previously mentioned results. Of
note, if the one patient who received surgery at the age of
89 years and with considerable cardiac comorbidity (coro-
nary artery disease and coronary artery bypass grafting)
were to be excluded, perioperative mortality would be 1%
(1/120) for elective surgeries. For emergent surgeries, we
noted a mortality of 3%, which is, however, not signiﬁcantly
different from the elective mortality and is in line with a
large meta-analysis of acutely thrombosed aneurysms
(3.2%).11 With regard to perioperative morbidity, it has
been stressed that open surgery is endowed with speciﬁccomplications such as surgical site infections and hema-
toma.20 In our series, the overall rate of hematoma was
8%, again being comparable with other studies.19 The over-
all rate of fasciotomies was 5%, and was signiﬁcantly greater
in the emergent group (16%; P ¼ .0005).
With regard to long-term performance, open surgery in
our experience is a durable procedure with only a minor rate
of secondary interventions, evidenced by an assisted primary
patency of 92.1% and 84.3% at 5 and 10 years, respectively,
comparable with other large studies.7 The occurrence of
late aneurysm perfusion warrants further discussion. In
the literature, incidences show a wide range from high
(33%-38%)6,13 to intermediate (8%-15%),12,21,22 down to
very low incidences of 0%23 and 3.2%.7 It has been advo-
cated that complementary endoaneurysmorraphy would
be superior to simple ligation and bypass in preventing
late recurrence,7 but there are also reports of no recurrence
after ligation and bypass.23 In the Swedvasc study,13 the
inﬂow vessel had not been ligated in most cases of repeat
surgery for aneurysm recurrence. In this regard, it has to
be stressed, that varying techniques of ligation might be
used and a simple ligation might allow perfusion of the
aneurysm if not performed properly or if local atheroscle-
rotic wall changes are present. Therefore, at our institution,
we perform a double ligation with complete transsection of
the artery and we observed a low rate of 5.8% for aneurysm
recurrence/perfusion. Nonetheless, late aneurysm perfu-
sion, which can be considered endoleak, is observed after
endovascular therapy (7%) and open repair (9%).6
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With our study, which represents to our knowledge,
the second largest single-center series, and reports
extended follow-up to 12 years, our results provide evi-
dence that open surgical management of popliteal aneu-
rysms is a durable procedure with low mortality and
morbidity and excellent long-term patency (84.7% second-
ary patency at 12 years) and limb salvage (98.6% at 12 years
for elective cases) which translates into a favorable rate of
freedom from reintervention of 84.3% at ﬁve and 69.8%
at 10 years. In the emergency setting of acutely throm-
bosed aneurysms with severe limb ischemia, signiﬁcantly
increased rates for amputation and fasciotomy were noted,
and graft patency and survival were not inﬂuenced. There-
fore, we join other authors in advocating open surgery as
the current gold standard for management of popliteal an-
eurysms.2,6,24 At our institution, based on our results, we
predominantly perform open surgery for popliteal aneu-
rysms but we also have applied endovascular therapy in a
limited number of highly selected cases of patients consid-
ered unﬁt for open therapy. Therefore, the number of cases
was too small to allow inclusion as a study group. Nonethe-
less, although it is believed that endovascular therapy is un-
likely to displace open surgical therapy in the near future,24
it surely does provide a viable alternative for selected pa-
tients with high surgical risk and carries promising potential
for further device reﬁnement. In addition, endovascular
therapy carries potential for treatment in emergent situa-
tions, especially for ruptured aneurysms but possibly also
in acutely thrombosed aneurysms because recanalization
can be achieved rapidly using concomitant arterial lysis.
Therefore, meticulous assessment of patient comorbidities
and surgical risk evaluation is crucial to identify the sub-
group of our patients that will beneﬁt from the decreased
invasiveness of endovascular therapy.
The authors thank H. Binder and I. Hofmann, Insti-
tute for Medical Biometry and Epidemiology, University
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